Hi,
I tried to run ONCOCNV.sh (most recent version) on a set of 9 normal sample alignments to generate a baseline to call CNVs on a set of 8 tumor samples. I used an appropriate tab-delimited BED file (chr, start, end, amplicon ID, 0, and gene name), BAM alignments, and an Ensembl reference genome. All tool requirements were satisfied. However, I was getting the following error with processSamples.R:
running processSamples.R
Package 'mclust' version 5.4.5
Type 'citation("mclust")' for citing this R package in publications.
PSCBS v0.65.0 successfully loaded. See ?PSCBS for help.
Attaching package: ‘PSCBS’
The following objects are masked from ‘package:base’:
append, load
R.cache v0.13.0 (2018-01-03) successfully loaded. See ?R.cache for help.
Loading required package: lattice
Loading required package: grid
Loading required package: parallel
Error in mvnX(data = data, prior = prior) :
NA/NaN/Inf in foreign function call (arg 1)
Calls: predictClust ... eval -> eval -> mclustBIC -> mvn -> eval -> eval -> mvnX
In addition: Warning messages:
1: In chrom != "chrM" & chrom != "chrX" & chrom != "chrY" & chrom != :
longer object length is not a multiple of shorter object length
2: In chrom != "chrM" & chrom != "chrX" & chrom != "chrY" & chrom != :
longer object length is not a multiple of shorter object length
3: In chrom != "chrM" & chrom != "chrX" & chrom != "chrY" & chrom != :
longer object length is not a multiple of shorter object length
4: In rnorm(length(autoInd), 0, sdError[autoInd]) : NAs produced
Execution halted
I want to mention that the Control.stats.Processed.txt file from processControls.R contained some fields with missing values (NA) for mean and IC1-3. Replacing those values with arbitrary numbers did not seem to help. Any clues as to what could be causing this error would be much appreciated.
Thank you!
-
The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...08-27-2024, 04:44 AM -
Sequencing mRNA provides a snapshot of cellular activity, allowing researchers to study the dynamics of cellular processes, compare gene expression across different tissue types, and gain insights into the mechanisms of complex diseases. “mRNA’s central role in the dogma of molecular biology makes it a logical and relevant focus for transcriptomic studies,” stated Sebastian Aguilar Pierlé, Ph.D., Application Development Lead at Inorevia. “One of the major hurdles for...08-07-2024, 12:11 PM